Seasonal Influenza Vaccine 2017

The Australian Immunisation Handbook recommends influenza vaccination for anyone aged >6 months of age who wishes to protect themselves against influenza.

Only those individuals listed below are eligible for funded vaccine on the National Immunisation Program (NIP). Medical at risk conditions include

  • Pregnant women at any stage of pregnancy
  • All adults >65 years of age
  • Aboriginal and Torres Strait Islander children aged 6months to <5 years of age
  • Aboriginal and Torres Strait Islander people aged >15 years of age
  • Individuals >6 months of age predisposing them to severe influenza including
    • Cardiac disease
    • Chronic respiratory conditions
    • Chronic neurological conditions
    • Immunocompromising conditions
    • Diabetes and other metabolic disorders
    • Renal disease
    • Haematological disorders
    • Long term aspirin therapy in children aged 6 months to10 years (Increased risk of Reye Syndrome)

The Quadrivalent vaccine provides active immunisation against four influenza strains (2 Influenza A strains & 2 Influenza B strains)

  • A (H1N1) A/Michigan/45/2015 pdm09 – like virus
  • A (H3N2) A/Hong Kong/4801/2014 – like virus
  • B B/Phuket/3073/2013 – like virus
  • B/Brisbane/60/2008 – like virus

In 2017, three age specific Quadrivalent influenza vaccines will be available through the NIP funded program for those under 18 years of age.

Age Group Vaccine Dose Number of doses required in the first year of influenza vaccination Number of doses required
If previously received 1 or more doses of influenza vaccine
Minimum interval between dose 1 and dose 2
6 months to under 3 years of age FluQuadri® Junior vaccine (Sanofi) 0.25mL IM 2 1 4 weeks
> 3 years to <9 years

FluQuadri® vaccine (Sanofi) OR

Fluarixtetra® vaccine (GlaxoSmithKline)

0.5mL IM# 2 1 4 weeks
≥ 9 years

FluQuadri® vaccine (Sanofi) OR

Fluarixtetra® vaccine (GlaxoSmithKline)

0.5mL IM# 1* 1 4 weeks

*A two dose schedule is recommended for persons ≥ 9 years with certain immunocompromising conditions (i.e. haematopoietic stem cell transplant or solid organ transplant, patients receiving immunosuppressive therapy) receiving influenza vaccine for the first time post transplant (irrespective of their age).

# The preferred route of administration for influenza vaccines is by IM injection; however, they may also be given by the Subcutaneous route

Influenza vaccine and egg allergy

Based on prospective and retrospective studies of influenza vaccination in those with and without egg allergy (including egg anaphylaxis), the presence of egg allergy does not increase the risk of allergic reactions to the influenza vaccine.

  • The vaccine can be administered in community vaccination clinic as a single dose followed by the recommended 15-20 minute waiting period.
  • In individuals who have had anaphylaxis following administration of the influenza vaccine itself, further vaccination should be avoided without specialist allergy assessment.
  • If there is significant parental or health professional anxiety, the vaccine may be administered in primary care settings with a longer waiting period of 30 minutes.
  • Special precautions such as split dosing, prior allergy testing with the vaccines, allergy specialist review before vaccination or prolonged waiting times after administration are not required unless anaphylaxis to the influenza vaccine itself has occurred previously.

Influenza vaccine and pneumococcal conjugate vaccine (PCV) in children < 5 years

PCV13 and influenza vaccines can be co-administered on the same day. This includes infants at 6-months and 12-months of age.

Influenza vaccine and pregnancy

Pregnant women are more at risk of serious illness due to influenza compared to non-pregnant women. Developing influenza infection whilst pregnant can lead to pneumonia and can cause miscarriage or premature labour. Pregnant women are more likely to be hospitalised than non-pregnant women due to influenza infection. Moreover, influenza vaccination will protect the mother and baby unit from the risk of serious illness and hospitalisation.

  • Influenza vaccination is recommended for all pregnant women.

How to refer

To refer a patient to our Specialist Immunisation Clinic check the “Infectious Diseases” box when completing the Specialist Referral form.

Submit your referral via:
f: 1300 407 281
e: chq_lcch-ref@health.qld.gov.au
Post: PO Box 3474, South Brisbane 4101

When are immunisations due?

Queensland Health provide a comprehensive immunisation schedule to make it easier for parents and carers to keep their child’s immunisations up to date.

Find out more

For more information about the Ellen Barron Family Centre, including eligibility criteria, catchment area restrictions, location details and referral advice follow the links below:

For families and carers

For health professionals